ArticleOrphanet journal of rare diseases2020

Inhibition of the mechanistic target of rapamycin induces cell survival via MAPK in tuberous sclerosis complex.

Yiyang Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.